Pharmacological HSP90 inhibition phenocopies HSP90 disappearance and thus promotes further activation and binding of HSF1 to its cognate DNA response element, thereby fully inducing the unwanted HSR in cancer cells. Here, HSP90AB1 is linked to cancer.